Literature DB >> 7642639

The C terminus of mitosin is essential for its nuclear localization, centromere/kinetochore targeting, and dimerization.

X Zhu1, K H Chang, D He, M A Mancini, W R Brinkley, W H Lee.   

Abstract

Mitosin is a novel 350-kDa nuclear phosphoprotein that dramatically relocates from the evenly nuclear distribution in S phase to the centromere/kinetochore and mitotic apparatus in M phase. The dynamic relocalization of mitosin is accompanied by the phosphorylation of itself, suggesting that mitosin plays a role in mitotic progression. The molecular basis of nuclear localization and targeting of mitosin to the centromere/kinetochore were characterized using a set of epitope-tagged deletion mutants. The data indicate that the extreme C terminus (amino acids 2,487-3,113) of mitosin has both an independent centromere/kinetochore targeting domain and an unusually spaced bipartite nuclear localization signal. Moreover, the same centromere/kinetochore targeting domain was shown to be essential for the ability of mitosin to bind to itself or other putative mitosin-associated proteins through use of the yeast two-hybrid system. These results suggest that the C terminus of the mitosin is essential for its role in influencing cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642639     DOI: 10.1074/jbc.270.33.19545

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Deciphering the nuclear import pathway for the cytoskeletal red cell protein 4.1R.

Authors:  P Gascard; W Nunomura; G Lee; L D Walensky; S W Krauss; Y Takakuwa; J A Chasis; N Mohandas; J G Conboy
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

2.  A spindle checkpoint functions during mitosis in the early Caenorhabditis elegans embryo.

Authors:  Sandra E Encalada; John Willis; Rebecca Lyczak; Bruce Bowerman
Journal:  Mol Biol Cell       Date:  2004-12-22       Impact factor: 4.138

3.  Cytoplasmic LEK1 is a regulator of microtubule function through its interaction with the LIS1 pathway.

Authors:  Victor Soukoulis; Samyukta Reddy; Ryan D Pooley; Yuanyi Feng; Christopher A Walsh; David M Bader
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

4.  The human Nup107-160 nuclear pore subcomplex contributes to proper kinetochore functions.

Authors:  Michela Zuccolo; Annabelle Alves; Vincent Galy; Stéphanie Bolhy; Etienne Formstecher; Victor Racine; Jean-Baptiste Sibarita; Tatsuo Fukagawa; Ramin Shiekhattar; Tim Yen; Valérie Doye
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

5.  CMF1-Rb interaction promotes myogenesis in avian skeletal myoblasts.

Authors:  J Brian Robertson; Tianli Zhu; Shampa Nasreen; Dawn Kilkenny; David Bader; Ellen Dees
Journal:  Dev Dyn       Date:  2008-05       Impact factor: 3.780

6.  Murine CENP-F regulates centrosomal microtubule nucleation and interacts with Hook2 at the centrosome.

Authors:  Katherine L Moynihan; Ryan Pooley; Paul M Miller; Irina Kaverina; David M Bader
Journal:  Mol Biol Cell       Date:  2009-09-30       Impact factor: 4.138

7.  Structural requirements and dynamics of mitosin-kinetochore interaction in M phase.

Authors:  X Zhu
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

8.  Regulation of Cenp-F localization to nuclear pores and kinetochores.

Authors:  Alessandro Berto; Valérie Doye
Journal:  Cell Cycle       Date:  2018-09-20       Impact factor: 4.534

9.  Mechanism for G2 phase-specific nuclear export of the kinetochore protein CENP-F.

Authors:  Kyle M Loftus; Heying Cui; Elias Coutavas; David S King; Amanda Ceravolo; Dylan Pereiras; Sozanne R Solmaz
Journal:  Cell Cycle       Date:  2017-07-19       Impact factor: 4.534

10.  Murine CENPF interacts with syntaxin 4 in the regulation of vesicular transport.

Authors:  Ryan D Pooley; Katherine L Moynihan; Victor Soukoulis; Samyukta Reddy; Richard Francis; Cecilia Lo; Li-Jun Ma; David M Bader
Journal:  J Cell Sci       Date:  2008-09-30       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.